FIRST CHINA PHARMACEUTICAL GROUP, INC. - FORM 10-K/A - EX-32.1 - SECTION 906 CERTIFICATION - November 19, 2012

Attached files

file filename
10-K/A - AMENDMENT NO.4 TO ANNUAL REPORT ENDED MARCH 31, 2011 - FIRST CHINA PHARMACEUTICAL GROUP, INC.form10ka4.htm
EX-32.1 - SECTION 906 CERTIFICATION - FIRST CHINA PHARMACEUTICAL GROUP, INC.exhibit32-1.htm
EX-31.2 - SECTION 302 CERTIFICATION - FIRST CHINA PHARMACEUTICAL GROUP, INC.exhibit31-2.htm
EX-31.1 - SECTION 302 CERTIFICATION - FIRST CHINA PHARMACEUTICAL GROUP, INC.exhibit31-1.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

     In connection with this Annual Report on Form 10-K/A of First China Pharmaceutical Group, Inc. (the “Company”) for the period ended March 31, 2011 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned, in the capacity and on the date indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to her knowledge:

     1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

     2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

  Date: November 19, 2012
     
  By: /s/ Yi Jia Li
    Name: Yi Jia Li
    Title: Chief Financial Officer (Principal Financial Officer
    and Principal Accounting Officer)

FIRST CHINA PHARMACEUTICAL GROUP, INC. Reports